How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?Published in:Glioma (2589-6113), 2023, v. 6, n. 3, p. 29, doi. 10.4103/glioma.glioma_8_23By:Wong, Eric T.Publication type:Article
Gliosarcoma in a patient with triple-negative breast cancer: A case report.Published in:Glioma (2589-6113), 2023, v. 6, n. 3, p. 23, doi. 10.4103/glioma.glioma_7_23By:Guojie Zhao;Wenxian Huang;Haiwei LianPublication type:Article